1. Home
  2. GRC vs CSTL Comparison

GRC vs CSTL Comparison

Compare GRC & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gorman-Rupp Company (The)

GRC

Gorman-Rupp Company (The)

HOLD

Current Price

$48.05

Market Cap

1.3B

Sector

Industrials

ML Signal

HOLD

Logo Castle Biosciences Inc.

CSTL

Castle Biosciences Inc.

HOLD

Current Price

$38.63

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRC
CSTL
Founded
1933
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Fluid Controls
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.1B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
GRC
CSTL
Price
$48.05
$38.63
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$42.83
AVG Volume (30 Days)
87.5K
363.9K
Earning Date
02-06-2026
11-03-2025
Dividend Yield
1.59%
N/A
EPS Growth
31.51
N/A
EPS
1.91
N/A
Revenue
$678,522,000.00
$343,530,000.00
Revenue This Year
$4.94
$1.69
Revenue Next Year
$4.02
N/A
P/E Ratio
$24.97
N/A
Revenue Growth
3.19
10.15
52 Week Low
$30.87
$14.59
52 Week High
$52.02
$42.18

Technical Indicators

Market Signals
Indicator
GRC
CSTL
Relative Strength Index (RSI) 50.40 54.00
Support Level $48.11 $38.75
Resistance Level $50.58 $39.76
Average True Range (ATR) 1.09 1.18
MACD -0.25 -0.44
Stochastic Oscillator 15.83 19.71

Price Performance

Historical Comparison
GRC
CSTL

About GRC Gorman-Rupp Company (The)

Gorman-Rupp Co designs, manufactures, and globally sells pumps & pump systems for use in water, wastewater, construction, dewatering, industrial, petroleum, original equipment, agriculture, fire protection, heating, ventilating & air conditioning, military, and other liquid-handling applications. It operates in one business segment, the manufacture & sale of pumps and pump systems, and generates revenue from the same. Geographically, it generates the majority of revenue from the United States.

About CSTL Castle Biosciences Inc.

Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.

Share on Social Networks: